• Skip to main content
  • Skip to primary sidebar

Cohen & Malad, LLP

Giving Power to Your Voice for Over 50 Years

Google Reviews
866.446.7478317.636.6481
Make a Payment free consult

  • About Us
  • Attorneys
  • Services
    • Appellate Law
    • Business Services & Litigation
    • Class Action
    • Eminent Domain
    • Family Law
    • Medical Malpractice
    • Personal Injury
    • Pharmaceutical & Medical Device Litigation
    • Real Estate Services & Litigation
    • Sexual Abuse
  • Testimonials
  • Resources
    • Alerts
    • Firm News
    • Video Library
    • Blog
    • FAQs
  • Contact

Home » CDC Recommends the Immediate Discontinuation of EzriCare Artificial Tears

CDC Recommends the Immediate Discontinuation of EzriCare Artificial Tears

By Cohen & Malad, LLP

The Centers for Disease Control and Prevention (CDC) has recommended clinicians and patients immediately discontinue the use of EzriCare Artificial Tears, an over-the-counter eye drop. The CDC issued a statement stating that recent epidemiology and laboratory evidence linked various infections with the drops.

If you or someone you know has suffered an infection following the use of EzriCare Artificial Tears, contact us. Our product liability attorneys have decades of experience fighting large corporations in dangerous medical device litigation and getting people compensation for their injuries. We can provide you with a no-cost case evaluation. Contact us now.

Primary Sidebar

ASK ABOUT SCHEDULING AN INITIAL FREE CONSULTATION TODAY

  • This field is for validation purposes and should be left unchanged.

Cohen & Malad, LLP

One Indiana Square Suite 1400
Indianapolis, Indiana 46204
(317) 636-6481
Toll Free: (866) 446-7478

Copyright © 2023 Cohen & Malad, LLP
Disclaimer Privacy Policy

  • About Us
  • Attorneys
  • Services
    ▼
    • Appellate Law
    • Business Services & Litigation
    • Class Action
    • Eminent Domain
    • Family Law
    • Medical Malpractice
    • Personal Injury
    • Pharmaceutical & Medical Device Litigation
    • Real Estate Services & Litigation
    • Sexual Abuse
  • Testimonials
  • Resources
    ▼
    • Alerts
    • Firm News
    • Video Library
    • Blog
    • FAQs
  • Contact